The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia-Reference-Cited by-同舟云学术

The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia

Published:2005-05 Issue:5 Volume:54 Page:677-681
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Saklamaz Ali,Comlekci Abdurrahman,Temiz Aysegul,Caliskan Sezer,Ceylan Cengiz,Alacacioglu Ahmet,Yesil Sena

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study;Castelli;JAMA,1986

2. Effect of lovastatin on hemorheology in type II hyperlipoproteinemia;Koppensteiner;Atherosclerosis,1990

3. Plasma viscosity and the risk of coronary heart disease. Results from the MONICA-Augsburg Cohort Study, 1984 to 1992;Koenig;Arterioscler. Thromb. Vasc. Biol.,1998

4. Increased blood viscosity and fibrinolytic activity in type II hyperlipoproteinemia;Lowe;Lancet,1982

5. Hemorheological profile in patients with cardiovascular risk factors;Vaya;Haemostasis,1996

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Needs and Experiences of Patients with Hypertriglyceridemia: Social Media Listening Infosurveillance Study (Preprint);2022-11-26

2. Rice (Oryza sativa) Bran;Oilseeds: Health Attributes and Food Applications;2020-10-31

3. A transition metal-free approach towards the regioselective synthesis of β-carboline tethered pyrroles and 2,3-dihydro-1H-pyrroles;New Journal of Chemistry;2020

4. Tandem Synthesis of 3,4-Disubstituted Pyrroles from Aldehydes, 1,3-Diketones and TosMIC Under Metal-Free Conditions;ChemistrySelect;2018-03-12

5. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease;Endocrine Practice;2017-04